FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:1611-1613 April 14, 2005 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: Recent studies suggesting that C-reactive protein (CRP) may be an important risk marker for cardiovascular disease have stimulated the demand for testing. Nevertheless, many physicians may be unfamiliar with high-sensitivity CRP measurements. In fact, no description of the distribution of CRP values for the entire adult population (and relevant subgroups) in the United States is readily available to clinicians. We therefore sought to summarize the distribution of CRP for all U.S. adults by age, sex, and race or ethnic background.

We analyzed components of the most recent data released from the National Health and Nutrition Examination Survey . . . [Full Text of this Article]

This article has been cited by other articles:

• Grootendorst, D. C., de Jager, D. J., Brandenburg, V. M., Boeschoten, E. W., Krediet, R. T., Dekker, F. W., The NECOSAD Study Group, (2007). Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients no additional power for mortality prediction with high-sensitivity CRP. Nephrol Dial Transplant 22: 3277-3284 [Abstract] [Full Text]  
• Schett, G., Kiechl, S., Weger, S., Pederiva, A., Mayr, A., Petrangeli, M., Oberhollenzer, F., Lorenzini, R., Redlich, K., Axmann, R., Zwerina, J., Willeit, J. (2006). High-Sensitivity C-Reactive Protein and Risk of Nontraumatic Fractures in the Bruneck Study. Arch Intern Med 166: 2495-2501 [Abstract] [Full Text]  
• Koh, K. K., Yoon, B.-K. (2006). Controversies regarding hormone therapy: Insights from inflammation and hemostasis. Cardiovasc Res 70: 22-30 [Abstract] [Full Text]  
• Pepys, M. B., Hawkins, P. N., Kahan, M. C., Tennent, G. A., Gallimore, J. R., Graham, D., Sabin, C. A., Zychlinsky, A., de Diego, J. (2005). Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein Itself. Circ. Res. 97: e97-e103 [Abstract] [Full Text]